期刊文献+

羟基喜树碱半固体脂质纳米粒制备工艺研究 被引量:3

Study on the Preparation Technology of Hydroxycamptothecin Semisolid Lipid Nanoparticles
下载PDF
导出
摘要 目的制备羟基喜树碱的半固体脂质纳米粒(HCPT-SSLN)。方法在单因素考察的基础上,通过正交设计优选处方和制备工艺,并对优化条件下制备的HCPT-SSLN纳米溶液进行质量评价。结果制备的HCPT-SSLN平均粒径为130.5 nm,多分散系数为0.18,载药量为2.51%,包封率为79.19%,ξ电位为-33.1mV;纳米溶液4℃下放置6个月,纳米粒外观、粒径及包封率无明显变化。结论所制备的HCPT-SSLN包封率和载药量较高,粒径分布均匀,稳定性良好,为羟基喜树碱的临床应用提供了更广阔的前景。 Objective To prepare hydroxycamptothecin semisolid lipid nanoparticles ( HCPT - SSLN). Methods Based on the single - factor experiment, the HCPT - SSLN was prepared by orthogonal design for optimization of formulation and technology. Then the obtained SSLN was evaluated. Results The mean particle size of the prepared HCPT -SSLN was 130.5nm, Polydispersity index(PI) was 0.18, drug loading(DL) was 2.51% , entrapment efficiency(EE) was 79.19% , ξ potential was - 33. lmV; Placed at 4℃ for 6 months, the appearance, particle size and entrapment efficiency of SSLN were all stable. Conclusion The HCPT- SSLN has high entrapment efficiency and drug loading, uniform particle size, good stability, which provides an extensive prospect for clinical application of HCPT.
出处 《时珍国医国药》 CAS CSCD 北大核心 2009年第1期127-129,共3页 Lishizhen Medicine and Materia Medica Research
基金 2003年广东省科技计划项目(No.2003A1070103)
关键词 羟基喜树碱 半固体脂质纳米粒 制备工艺 Hydroxycamptothecin Semisolid lipid nanoparticles (SSLN) Preparation
  • 相关文献

参考文献9

  • 1杨绮华.药物载体系统的研究进展[J].中国新药杂志,2002,11(8):593-596. 被引量:15
  • 2王建新,张志荣.固体脂质纳米粒的研究进展[J].中国药学杂志,2001,36(2):73-76. 被引量:62
  • 3Iyer L, Ratain MJ. Clinical pharmacology of camptothecins[ J]. Cancer Chemother Parmacol, 1998, 42:31.
  • 4Urasaki Y, Laco G, Takebayashi Y, et al. Use of camptothecin - resistant mammalian cell lines to evaluate the role of topoisomerase Ⅰ in the antiproliferative activity of the indolocarbazole, NB - 506, and its topoisomerase Ⅰ binding site[ J]. Cancer Res, 2001, 61 (2) :504.
  • 5Jung LL, Zamboni WC. Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it? [ J]. Drug Ressistance Updates, 2001,4(4) :273.
  • 6张力,李苏,廖海,姜文奇,管忠震.羟基喜树碱Ⅰ期药代动力学及人体耐受性临床研究[J].癌症,2001,20(12):1391-1395. 被引量:81
  • 7Burke TG, Mishra AK, Wani MC, et al. Lipid bilayer partitioning and stability of camptothecin drugs [ J ]. Biochemistry, 1993, 32 (20) :5352.
  • 8Muller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs [J]. Int J Pharm, 2002, 242 ( 1 / 2) :121.
  • 9Coon JS, Knudson W, Clodfeher K, et al. Solutol HS 15, nontoxic polyoxyethylene esters of 12 -hydroxystearic acid, reverses multidrug resistance[J]. Cancer Res,1991 Feb 1 ; 51 (3) :897.

二级参考文献32

共引文献151

同被引文献51

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部